Evidence-based approach to early outpatient treatment of SARS-CoV-2 (COVID-19) infection

Abstract

Misinformation and promotion of well-intended but disproved therapies for COVID-19 have plagued evidence-based shared decision-making throughout the COVID-19 pandemic. In times of crisis, clinicians may feel that their strong inclination to prescribe potentially harmful, unproven therapies on behalf of their patients is supported by beneficence. Clinicians should mindfully identify and avoid commission bias during this pandemic, especially as more data have accumulated to assist with clinically sound decision-making. We describe a more evidence-based approach to treatment of early outpatient COVID-19, stressing the availability of Food and Drug Administration emergency use authorization therapies and considering plausibly beneficial, nonprescription supplements that are generally regarded as safe.

Please click here to read the article
Please click here to subscribe to BUMC Proceedings

Faculty credentials/disclosure 

Dr. Jun Zhang received his MD and MS in human pathology and has worked as a research pharmacologist for approximately 30 years. Dr. Kristen M. Tecson received her PhD in statistical science and has worked in the field of cardiovascular research for the past 5 years. Dr. Peter A. McCullough (MD, MPH) is a practicing cardiologist and an internationally recognized authority on the role of chronic kidney disease as a cardiovascular risk state. The authors and planner report no conflicts of interest. This work was partially funded by the Baylor Health Care System Foundation.

Process

Click the take course button, pay any relevant fee, take the quiz, complete the evaluation, and claim your CME credit.  You must achieve 100% on the quiz with unlimited attempts available.

  • By completing this process, you are attesting that you have read the journal article.
  • By claiming ABIM MOC credit you are providing permission to have your data uploaded into the Accreditation Council for Continuing Medical Education (ACCME) system for transfer to the American Board of Internal Medicine (ABIM).

You will need to verify that your profile contains your correct birthdate (mm/dd) and ABIM diplomate number. For your convenience, please click here to verify your ABIM diplomate number. 

Expiration date

Credit eligibility for this article is set to expire on July 1, 2023.

Target Audience

All physicians

Learning Objectives

After completing the article, the learner should be able to:

  • Identify evidence-based therapy for outpatient SARS-CoV-2 (COVID-19) infection
  • Identify nonprescription supplements generally regarded as safe for therapy of SARS-CoV-2 (COVID-19) infection.
  • Define commission bias
Course summary
Available credit: 
  • 1.00 American Board of Internal Medicine (ABIM) MOC Part 2
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 1.00 AMA PRA Category 1 Credit
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance
Course opens: 
07/01/2021
Course expires: 
12/31/2022
Cost:
$25.00
Rating: 
0

Accreditation

The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

AMA PRA Category 1 Credit

The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Available Credit

  • 1.00 American Board of Internal Medicine (ABIM) MOC Part 2
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 1.00 AMA PRA Category 1 Credit
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance

Price

Cost:
$25.00
Please login or register for this course.